Were you looking for more information about Denileukin Diftitox? Denileukin diffitox is a common misspelling of denileukin diftitox.
Adults with cutaneous T-cell lymphoma that has not improved or has come back after other forms of treatment may benefit from denileukin diftitox (Ontak®). This medication works by binding to the surface of certain cancer cells and releasing a type of toxin that kills the cells.
Denileukin diftitox is available by prescription only and is administered as an intravenous (IV) infusion by a healthcare provider for five days in a row, once every three weeks for eight cycles. Most people using this drug will develop some type of side effect, such as fever, vomiting, or diarrhea.
(Click Denileukin Diftitox for a more in-depth look at this medication and its specific uses, effects, dosing guidelines, and other potential side effects. You can also click any of the links in the box to the right for specific information.)